Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear
Phase 2
Withdrawn
- Conditions
- MCL Tear
- Interventions
- Drug: salineBiological: Plasma Rich in Growth Factors (PRGF)
- Registration Number
- NCT00743886
- Lead Sponsor
- Meir Medical Center
- Brief Summary
To evaluate the influence of Plasma Rich in Growth Factors (PRGF) on the healing process of medial collateral ligament (MCL) tear.
- Detailed Description
Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- age 18-40 years old
- diagnosed MCL tear grade 2/3
Exclusion Criteria
- pregnancy
- mental or physical disabilities
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 saline saline 1 Plasma Rich in Growth Factors (PRGF) Plasma Rich in Growth Factors (PRGF)
- Primary Outcome Measures
Name Time Method time and efficiency of healing 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Meir Medical Center
🇮🇱Kfar Saba, Israel